Publications by authors named "Michael Althaus"

Claim this Profile
E
Efficacy and Safety of IncobotulinumtoxinA in Older Patients with Upper Limb Spasticity: A Pooled Analysis.
Michael C Munin, Alexandre Camões-Barbosa, Carlos Cordero-García, Alessio Baricich, Stefano Carda, Michael Althaus

Geriatrics (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in Quality-of-Life-Related Outcomes Following Treatment with IncobotulinumtoxinA in Adults with Limb Spasticity: A Pooled Analysis.
Franco Molteni, Jörg Wissel, Klemens Fheodoroff, Michael C Munin, Atul T Patel, Michael Althaus

Toxins (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pain Reduction in Cervical Dystonia Following Treatment with IncobotulinumtoxinA: A Pooled Analysis.
Alberto Albanese, Jörg Wissel, Wolfgang H Jost, Anna Castagna, Michael Althaus

Toxins (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pooled Safety Analysis of IncobotulinumtoxinA in the Treatment of Neurological Disorders in Adults.
Wolfgang H Jost, Petr Kaňovský, Michael A Hast, Angelika Hanschmann, Michael Althaus

Toxins (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spasticity-related pain in children/adolescents with cerebral palsy. Part 2: IncobotulinumtoxinA efficacy results from a pooled analysis.
Michaela Bonfert, Florian Heinen, Petr Kaňovský, A Sebastian Schroeder, Henry G Chambers, Michael Althaus

J Pediatr Rehabil Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety Profile and Lack of Immunogenicity of IncobotulinumtoxinA in Pediatric Spasticity and Sialorrhea: A Pooled Analysis.
Steffen Berweck, Marta Banach, Deborah Gaebler-Spira, Henry G Chambers, A S Schroeder, Michael Althaus

Toxins (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spasticity-related pain in children/adolescents with cerebral palsy. Part 1: Prevalence and clinical characteristics from a pooled analysis.
Florian Heinen, Michaela Bonfert, Petr Kaňovský, A Sebastian Schroeder, Henry G Chambers, Michael Althaus

J Pediatr Rehabil Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pain Reduction in Adults with Limb Spasticity Following Treatment with IncobotulinumtoxinA: A Pooled Analysis.
Jörg Wissel, Alexandre Camões-Barbosa, Georg Comes, Michael Althaus, Astrid Scheschonka

Toxins (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IncobotulinumtoxinA Efficacy/Safety in Upper-Limb Spasticity in Pediatric Cerebral Palsy: Randomized Controlled Trial.
Edward Dabrowski, Henry G Chambers, Deborah Gaebler-Spira, Marta Banach, Petr Kaňovský, Michael Althaus

Pediatr Neurol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Placebo-Controlled Clinical Trial of IncobotulinumtoxinA for Sialorrhea in Children: SIPEXI.
Steffen Berweck, Marcin Bonikowski, Heakyung Kim, Michael Althaus, Birgit Flatau-Baqué

Neurology· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration and onset of effect of incobotulinumtoxinA for the treatment of blepharospasm in botulinum toxin-naïve subjects.
Dimos D Mitsikostas, Andrzej Dekundy, Angelika Hanschmann, Michael Althaus, Astrid Scheschonka

Curr Med Res Opin· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained efficacy of incobotulinumtoxina repeated injections for upper-limb post-stroke spasticity: A post hoc analysis.
Petr Kaňovský, Elie P Elovic, Michael C Munin, Angelika Hanschmann, Irena Pulte, Michael Althaus

J Rehabil Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of Treatment Effect Using IncobotulinumtoxinA for Upper-limb Spasticity: A Analysis.
Petr Kaňovský, Elie P Elovic, Angelika Hanschmann, Irena Pulte, Michael Althaus

Front Neurol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability and Efficacy of Customized IncobotulinumtoxinA Injections for Essential Tremor: A Randomized, Double-Blind, Placebo-Controlled Study.
Mandar Jog, Jack Lee, Astrid Scheschonka, Robert Chen, Farooq Ismail, Michael Althaus

Toxins (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IncobotulinumtoxinA for the Treatment of Blepharospasm in Toxin-Naïve Subjects: A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Trial.
Dimos D Mitsikostas, Andrzej Dekundy, Kati Sternberg, Michael Althaus, Fernando Pagan

Adv Ther· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post hoc analysis of the improvement in shoulder spasticity and safety observed following treatment with incobotulinumtoxinA.
Jörg Wissel, Djamel Bensmail, Astrid Scheschonka, Birgit Flatau-Baqué, Olivier Simon, Michael Althaus

J Rehabil Med· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of neramexane in patients with moderate to severe subjective tinnitus.
Markus Suckfüll, Michael Althaus, Barbara Ellers-Lenz, Alexander Gebauer, Roman Görtelmeyer

BMC Ear Nose Throat Disord· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic hyperalgesia.
Thomas Klein, Walter Magerl, Angelika Hanschmann, Michael Althaus, Rolf-Detlef Treede

Eur J Pain· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of dihydroergocryptine in human plasma and urine samples using on-line sample extraction-column-switching reversed-phase liquid chromatography-mass spectrometry.
Gerhard Friedrich, Kurt Appel, Thorsten Rose, Martina Wangemann, Michael Althaus

J Chromatogr B Analyt Technol Biomed Life Sci· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single dose pharmacokinetics of alpha-dihydroergocryptine in patients with moderate to severe renal insufficiency.
Christian de Mey, Władyslaw Sułowicz, Tomasz Stompór, Eric Ezan, Angelika Retzow, Michael Althaus

Arzneimittelforschung· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis